A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

Summary

This trial is conducted in Asia. The aim of this trial is to confirm the superiority of insulin degludec/liraglutide versus insulin degludec in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus after 26 weeks of treatment

Timeline

Start

2017-05-26

Primary completion

2019-03-05

Completion

2019-04-04

Outcome

Met primary endpoint

registry analysis (superiority test); Insulin Degludec/Liraglutide vs Insulin Degludec; p <.0001; Treatment contrast -0.92 (95% CI -1.09 to -0.75); ANCOVA NCT03175120 ↗

Drugs

Indications